ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

STX Shield Therapeutics Plc

2.05
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.05 2.00 2.10 2.05 2.05 2.05 1,009,938 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.39 15.9M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 2.05p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 12.75p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £15.90 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.39.

Shield Therapeutics Share Discussion Threads

Showing 22526 to 22545 of 23375 messages
Chat Pages: Latest  911  910  909  908  907  906  905  904  903  902  901  900  Older
DateSubjectAuthorDiscuss
28/10/2023
13:41
Absolutely no idea and not sure that matters. The CEO is the target for those who want to challenge this share as is the only weakness I see. That said this clown has STX sitting prime for a takeover.
bolitix
28/10/2023
09:58
How many warrants out there then.
goforgold1
28/10/2023
09:11
We have a donkey as CEO. That is the only risk but it is one that took us down from 57p when the board felt the travel direction was meant to be North. To be fare on STX they have gone in the right direction for nearly 2 years and hitting targets or thereabouts over that time. 100k+ sales YE23 has a significant growth shout about it factored over 2 years. The share price is lagging but will inevitably follow
bolitix
27/10/2023
17:51
still a hold from me
a few ripple after a big drop
but my opinion is still not changed
expect positive news in the last two months of the year.

qipincha
27/10/2023
17:12
700 million shares in issue How many warrants Talk about dilution
rodney101
27/10/2023
17:11
Looking at 2p
rodney101
27/10/2023
16:19
Disappointing to see a tick below 6p again. On the other hand I can easily sell 200k in one go late on a Friday afternoon, but 200k dummy purchase goes to NT. Hopefully we will find some support next week. Have a nice weekend all.
cyberbub
27/10/2023
14:35
CFO gone as well total RED FLAG Looks like dodgy dealing going on for him to leave .
goforgold1
27/10/2023
14:33
52 week low total Scam this now be carful lot further to fall yet . Market telling you so sell after sell after sell
goforgold1
26/10/2023
10:53
Lots of vegetarians/vegans around, I don't think their diet contains much Iron
theclangers
26/10/2023
10:00
Write up on pg 24 of todays Times re the absorption of iron tablets. One in ten women has iron deficiency anaemia and it is often caused by blood loss or pregnancy, affecting one in five women of child bearing age. Treatment is iron tablets taken for 6 months. 4 times absorption when taken with orange juice. Dr Carrie Ruxton, 'More than a third of women and girls don't get enough iron in their diets while up to 10% are clinically deficient in iron.'
r9505571
20/10/2023
17:06
Unless your ramping it of course !!
amaretto1
20/10/2023
17:00
This thread is almost entirely filtered for me at the mo :-) :-(
cyberbub
20/10/2023
16:14
Just announced they are presenting here
purchaseatthetop
20/10/2023
14:38
I really hope you're right, because if you are, they'll want to sell those 12p shares in advance for circa 30p. You know the game, you fell for it on ENET only yesterday heheheheheheheheheheheh
the imperialist
20/10/2023
11:54
Not looking great here at all . Sales will tail off and money becoming tight . Avoid the hype and look at the numbers m
bones698
20/10/2023
10:20
Andy Hurley was recruited as CCO in April 23 and his job is to increase the gross margin. Nothing would or could have been achieved to 30/6/23 but hopefully that will change as it is Uber critical. I think they were prioritising simple prescription numbers and not quality of revenues.
purchaseatthetop
20/10/2023
09:02
Hopefully no more funding rounds, with signs of accelerated growth into FY 2024/25 - sales are behind previous guidance, but still significant. Perhaps measurable in terms of 100s of thousands sale units, according to Edison (+350,000). The disappointing unit sale price should also increase towards $200. Looking for $70m sales next year.
weatherman
20/10/2023
08:19
Consensus revenue estimates decrease by 11%The consensus outlook for fiscal year 2023 has been updated.2023 revenue forecast fell from US$18.0m to US$16.0m.EPS estimate unchanged from -US$0.036 per share at last update.Pharmaceuticals industry in the United Kingdom expected to see average net income growth of 112% next year.Consensus price target of UK£0.47 unchanged from last update.Share price rose 6.5% to UK£0.066 over the past week.
r9505571
20/10/2023
07:40
Morning love xxx :-)
the imperialist
Chat Pages: Latest  911  910  909  908  907  906  905  904  903  902  901  900  Older

Your Recent History

Delayed Upgrade Clock